Sall1 is a transcriptional regulator defining microglia identity and function

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are the primary immune cells of the central nervous system (CNS).
• Identifying unique markers for microglia is crucial for understanding their function and for targeted manipulation.
• Sall1 has been identified as a potential microglial signature gene.

Purpose of the Study:

• To investigate the role of Sall1 in maintaining microglial identity and function within the CNS.
• To explore the potential of Sall1 for microglia-specific gene targeting and manipulation.
• To understand the consequences of Sall1 inactivation on microglial behavior and CNS homeostasis.

Main Methods:

• Gene expression profiling to identify microglial signature genes.
• Microglia-specific gene targeting using Sall1.
• In vivo inducible inactivation of the murine Sall1 locus.
• Analysis of microglial phenotype, neurogenesis, and tissue homeostasis.

Main Results:

• Sall1 is specifically expressed in microglia within the CNS, distinguishing them from other mononuclear phagocytes.
• The study identified CSF1R's role in adult microglial maintenance and TGF-β receptor's role in suppressing microglial activation.
• Inducible inactivation of Sall1 in vivo converted microglia into inflammatory phagocytes.
• This conversion led to altered neurogenesis and disrupted CNS tissue homeostasis.

Conclusions:

• Transcriptional regulation by Sall1 is essential for maintaining microglial identity and physiological properties in the CNS.
• Sall1 enables microglia-specific manipulation in vivo, offering a tool for studying microglial function.
• Dysregulation of Sall1 impacts microglial behavior, leading to detrimental effects on brain health.